Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
3.760
-0.010 (-0.27%)
At close: Aug 28, 2026, 4:00 PM EDT
3.770
+0.010 (0.27%)
After-hours: Aug 28, 2026, 4:27 PM EDT
Neuphoria Therapeutics Employees
As of June 30, 2025, Neuphoria Therapeutics had 8 total employees, including 7 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,178,892
Market Cap
20.32M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 8 | 0 | - | 7 | 1 |
| Jun 30, 2024 | 8 | - | - | 8 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Longeveron | 38 |
| ABVC BioPharma | 19 |
| NewcelX | 12 |
| Cocrystal Pharma | 10 |
| Allarity Therapeutics | 8 |
| Akari Therapeutics, | 6 |
| Pasithea Therapeutics | 5 |
| Dyadic International | 5 |
NEUP News
- 5 weeks ago - Neuphoria Therapeutics Proxy statement: Proxy filing - Filings
- 5 weeks ago - Neuphoria Therapeutics to be acquired by Scancell - TheFly
- 5 weeks ago - Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing - GlobeNewsWire
- 2 months ago - Neuphoria Therapeutics confirms merger discussions with Scancell Holdings - TheFly
- 2 months ago - Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc - GlobeNewsWire
- 3 months ago - Neuphoria Therapeutics downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 3 months ago - Neuphoria Therapeutics Quarterly report: Q3 2026 - Filings
- 6 months ago - Neuphoria Therapeutics Quarterly report: Q2 2026 - Filings